Predicted Trait | |
Reported Trait | Lung and bronchus cancer |
Mapped Trait(s) | |
Additional Trait Information | PheCode 165.1 |
Score Construction | |
PGS Name | PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608 |
Development Method | |
Name | Pruning and Thresholding (P+T) |
Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=1e-10 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 14 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000118 |
Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
---|---|---|---|
GWAS Catalog: GCST000506 Europe PMC: 19836008 | 11,587 individuals | European | NR |
GWAS Catalog: GCST002466 Europe PMC: 24880342 | 27,209 individuals | European | NR |
GWAS Catalog: GCST004744 Europe PMC: 28604730 | 66,756 individuals | European | NR |
GWAS Catalog: GCST004746 Europe PMC: 28604730 | 24,108 individuals | European | NR |
GWAS Catalog: GCST004747 Europe PMC: 28604730 | 9,859 individuals | European | NR |
GWAS Catalog: GCST004748 Europe PMC: 28604730 | 85,716 individuals | European | NR |
GWAS Catalog: GCST004749 Europe PMC: 28604730 | 40,187 individuals | European | NR |
GWAS Catalog: GCST004750 Europe PMC: 28604730 | 63,053 individuals | European | NR |
GWAS Catalog: GCST006086 Europe PMC: 29924316 | 35,953 individuals | European | NR |
GWAS Catalog: GCST006087 Europe PMC: 29924316 | 32,338 individuals | European | NR |
GWAS Catalog: GCST006088 Europe PMC: 29924316 | 31,930 individuals | European | NR |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
Phenotype Definitions & Methods
|
Age of Study Participants
|
Participant Follow-up Time
|
Additional Ancestry Description
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828 | [
| European | MGI | PheCode:165.1; ICD9CM:162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 209.21, 231.2, V10.11; ICD10C... M:C33, C34, C34.0, C34.00, C34.01, C34.02, C34.1, C34.10, C34.11, C34.12, C34.2, C34.3, C34.30, C34.31, C34.32, C34.8, C34.80, C34.81, C34.82, C34.9, C34.90, C34.91, C34.92, C7A.090, D02.2, D02.20, D02.21, D02.22Show more | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source
|
Trait
|
PGS Effect Sizes (per SD change) |
Classification Metrics
|
Other Metrics
|
Covariates Included in the Model
|
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001076 | PSS000541| European Ancestry| 4,698 individuals | PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) | Reported Trait: Cancer of bronchus; lung | OR: 1.12 [1.015, 1.237] β: 0.114 (0.0507) | AUROC: 0.529 [0.503, 0.558] | Nagelkerke's Pseudo-R²: 0.00234 Brier score: 0.0827 Odds Ratio (OR, top 1% vs. Rest): 1.75 [0.796, 3.85] | age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE165.1_GWAS-Catalog-r2019-05-03-X165.1_PT_MGI_20200608 |
PPM020287 | PSS011324| European Ancestry| 1,202 individuals | PGP000539 | Lebrett MB et al. Genet Med (2023) |Ext. | Reported Trait: Lung cancer | — | AUROC: 0.731 [0.703, 0.759] | — | Age, sex, current smoking status, BMI, forced expiratory volume in 1 second/forced vital capacity ra... tioShow more | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods
|
Participant Follow-up Time
|
Sample Numbers
|
Age of Study Participants
|
Sample Ancestry
|
Additional Ancestry Description
|
Cohort(s)
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
PSS000541 | PheCode:165.1; ICD9CM:162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 209.21, 231.2, V10.11; ICD10C... M:C33, C34, C34.0, C34.00, C34.01, C34.02, C34.1, C34.10, C34.11, C34.12, C34.2, C34.3, C34.30, C34.31, C34.32, C34.8, C34.80, C34.81, C34.82, C34.9, C34.90, C34.91, C34.92, C7A.090, D02.2, D02.20, D02.21, D02.22Show more | — | [
| — | European | — | MGI | — |
PSS011324 | — | — | [ ,
47.0 % Male samples | Median = 65.0 years | European | — | MCRC | — |